專長 免疫學、生物工程 和 腫瘤研究
Background of Dr. Wang Kai-Wah
Pro. Wang Kai-Wah holds a PhD in medicine,
specializing in immunology, cytology,
bioengineering and oncology research.
1954 graduated from Beijing Medical University
1982 a medical professor in xiamen University and the chairwoman of Cancer Research Center
1984 a representative of China at 21th ICACT International Congress on Anti Cancer Treatment
1985 a representative of China at 5th Annual DNA Meeting
1986 a representative of China at 14th International Tumor Conference
1990 established Bionike Laboratories in America for development of biotech research
and medical production, and passed FDA inspection.
Dr. Wang Kai-Hua's achievements
1957-1959 researched and developed biochemistry of hepatitis and the test of cytochemistry.
1958-1974 insulin synthesis.
1963-1966 Researched and mixed an efficacious dose of "Jiang Bu Yao"
1972-1974 tumor-related antigens and skin test for cancer and found Calmodulin.
1974-1980 researched in cell factors, thymus hormone, interleukin-2(IL-2), interferon(INF alpha 2b) and
tumor necrosis factors used in clinical treatment.
After more than 20 years of research combining the bioengineering expertise of Dr. Wang Kai-Wah and state-of-the-art biochemical technologies - single-cell culture - a highly effective form of Calmodulin has been successfully extracted. The Calmodulin extract is then combined with lecithin using state-of-the-art technologies to form a nutrition compound that is stable and easily to absorb. This nutrition compound is then complemented with low-fat milk powder, soybean extract, and American ginseng to become the Ca-CAN Calmodulin supplement, which is very safe for consumption and highly efficacious in maintaining body health.